Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2022-06-10 00:00:00 ET · period of report 2022-06-08 · accession 0001567619-22-012667 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-10 | 2022-06-08 | ATRA | Koppikar Utpal | CFO | S - Sale | $5.63 | -5,853 | 203.5K | -3% | -$33.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-08 | S | D | 5,853 | $5.63 | 203,529 | D | — | — | (F2) Includes 1,790 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2022. |